Douglas B. Given, Director at ARROWHEAD PHARMACEUTICALS, INC. (ARWR), sold 5,547 shares at $21.90 ($122K) on 2024-12-16, disclosed to the SEC on 2024-12-18.
Scheduled sale ($122k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $21.90 | 5,000 | $110K | 90.1% |
| 2 | $22.04 | 547 | $12K | 9.9% |
| Total | $21.91 avg | 5,547 | $122K | 100% |
| Filing → |
| ARWR | SELL | 2023-03-01 | $29K | — | Filing → |
| ARWR | BUY | 2021-12-29 | $43K | — | Filing → |
| ARWR | SELL | 2021-09-10 | $326K | — | Filing → |